NinaTeresaGentileMD

Emergency Medicine • Philadelphia, PA

Professor and Vice Chair for Research Department of Emergency Medicine, Temple University School of Medicine

Join to view full profile

Dr. Gentile is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gentile's full profile

Already have an account?

Office
3401 N Broad St
Temple University Hospital
Philadelphia, PA 19140
Phone+1 215-707-8402

Fax+1 215-707-3494

Education & Training

Henry Ford Health/Henry Ford HospitalResidency, Emergency Medicine, 1986 - 1989
MCP-Hahnemann College of MedicineClass of 1986

Certifications & Licensure

PA State Medical License 1997 - 2024
CT State Medical License 1989 - 1993
MI State Medical License 1986 - 1990
American Board of Emergency Medicine Emergency Medicine

Clinical Trials

Procoagulant Effects of Hyperglycemia After Acute Stroke: A Pilot Study Start of enrollment: 2001 Oct 01
Completed
High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2009 Sep 01
Withdrawn
Not Applicable
The Effect of Implementing Hyper-acute Stroke Guidelines on Decision-Making for or Against Thrombolytic Therapy for Stroke in the Emergency Department
Completed
Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Start of enrollment: 2012 Apr 01
Completed
Phase 3
LIPS-A: Lung Injury Prevention Study With Aspirin Start of enrollment: 2012 Jan 01
Completed
Phase 2
Study of Procoagulation Markers in Stroke Patients Start of enrollment: 2012 Aug 01
Completed
Multi-arm Optimization of Stroke Thrombolysis Start of enrollment: 2019 Oct 15
Active, not recruiting
Phase 3
Roles: Contact
ARrest RESpiraTory Failure From PNEUMONIA Start of enrollment: 2020 Jun 01
Recruiting
Phase 3
Roles: Principal Investigator, Contact
ACTIV-6: COVID-19 Study of Repurposed Medications Start of enrollment: 2021 Jun 08
Active, not recruiting
Phase 3
Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation Start of enrollment: 2007 Mar 01
Completed
Phase 4
Emergency Department-Initiated Buprenorphine Validation Network Trial Start of enrollment: 2020 Jul 08
Recruiting
Phase 2
Roles: Contact
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial Start of enrollment: 2021 Dec 03
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia: A Randomized Clinical Trial.
Sean P Collins, Matthew S Shotwell, Jeffrey R Strich, Kevin W Gibbs, Marjolein de Wit
JAMA Network Open. 2024-12-02
Heart rate variability wrist-wearable biomarkers identify adverse posttraumatic neuropsychiatric sequelae after traumatic stress exposure.
Lauriane Guichard, Xinming An, Thomas C Neylan, Gari D Clifford, Qiao Li
Psychiatry Research. 2024-12-01
1 citations
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Russell L Rothman, Thomas G Stewart, Ahmad Mourad, David R Boulware, Matthew W McCarthy
JAMA Network Open. 2024-10-01

Press Mentions

Temple University Hospital to Study Experimental Stroke DrugNovember 10th, 2022
How Johnson & Johnson’s COVID-19 Vaccine Is Different from Pfizer’s and Moderna’sFebruary 26th, 2021
Johnson & Johnson – COVID Replace: Temple College Docs Search Philadelphians to Check Johnson & Johnson One-Dose COVID-19 VaccineNovember 21st, 2020
Join now to see all